← Back to blog

Startup Funding Strategy: Match Capital to Milestones

November 7, 2026
Startup Funding Strategy: Match Capital to Milestones

A startup funding strategy is a plan that ties each source of money to a specific milestone, so every dollar you raise buys evidence the next funder cares about. Start by naming what you must prove in the next 18 to 24 months. Then choose the mix of equity, grants, debt and revenue that proves it at the lowest cost in ownership and control.

This guide walks through the stages, how to size a raise, how the main U.S. sources compare, and how research-based founders can add non-dilutive funding to the mix.

Techtransferadvisors
Align Funding With Commercial Potential
Tech Transfer Advisors helps research-based startups navigate commercialization, intellectual property strategy, and investor networks as they plan their path to market.
Explore commercialization support

TL;DR

  • Investors fund in stages, and each stage answers one question for the next investor. Raise to reach the next answer, not for a round number.
  • Size a raise from milestones: forecast burn through the milestone, add one-time costs and a buffer, subtract cash on hand.
  • Equity, grants, loans and revenue each cost something different. Equity costs ownership, loans cost interest, grants cost time and paperwork.
  • Technical founders can use SBIR/STTR grants alongside private capital, but ownership rules must be checked before applying.
  • Start building investor relationships 6 to 12 months before you plan to raise.

Table of Contents

What a funding strategy actually decides

A strategy answers four questions in order: what must be true before the next round, how much money that takes, which sources fit that need, and when to start asking. Most founders begin with the second question and skip the first, which is how they raise too little or too much.

Four questions that guide startup funding decisions

The logic comes from how investors behave. Yale Ventures notes that investors typically provide capital in stages tied to technological and business milestones, and that a venture-backed company moves through multiple rounds, each with different expectations and valuation implications.

The choice between dilutive and non-dilutive capital belongs in the same plan. Yale defines non-dilutive funding as money that does not involve selling shares, such as grants, awards and loans that do not convert to equity. Dilutive capital is raised by selling equity, most commonly to angels and venture funds. Yale frames the choice as a strategic decision tied to your stage and goals, not a matter of principle.

How funding stages work

The stage names are conventions, not legal categories. A useful way to read them, as one venture investor explains, is that each stage answers a question for the next investor.

StageQuestion the money answersTypical U.S. size
Pre-seedCan the team build a first version?Average $276,000 on one cap table platform in Q2 2026
SeedWill anyone use or pay for it?About $3 million average in 2025
Series ADoes the business repeat?About $15 million average in 2025
Series B and laterCan the engine scale?Varies widely by sector

Treat the averages as context, not targets. A medical device company and a software company need very different amounts to reach the same stage, because regulatory work and clinical evidence cost real money.

Set milestones before you set a number

The best way to decide how much to raise, according to TechCrunch, is to list the milestones that prove the company is moving in the right direction. These can include product and technical de-risking, regulatory approvals, revenue targets and user engagement.

A good milestone is an observable change in company quality, not an activity. One fundraising worksheet puts it this way: hiring a team or growing are inputs, while the milestone is the evidence those inputs produce. Write it as: by month N, we will show X, measured by Y.

Examples a research-based founder might use:

  • By month 12, we will show a working prototype meeting a defined performance threshold in an independent lab.
  • By month 15, we will hold a signed option or license for the core patents.
  • By month 18, we will have two paid pilots with named customers.

Size the raise and plan the runway

The same worksheet gives a formula: target raise equals forecast net cash burn through the milestone, plus one-time costs, plus a contingency buffer, minus usable cash already on hand. Two practical rules sit on top of it.

  1. Add slack. TechCrunch's guidance is to estimate the resources and costs to reach each milestone, then add 30% to 50% for slippage.
  2. Plan for the raise itself. NYU Entrepreneurship recommends 18 to 24 months of runway, because a round takes about 6 months to close and 12 to 18 months of execution are needed to hit milestones that attract the next investors.

Advice on when to restart fundraising differs. A Y Combinator partner, as cited by 1752vc, suggests treating a round as roughly 24 months of money, starting the next raise with about 8 months left, and planning to hit milestones in about 16 months. That firm's own view is to start with 9 to 12 months of runway left. Another source advises starting with at least six to nine months of cash. The safe reading: never begin a raise with less than six months left, and more is better.

On ownership, the same 1752vc piece, citing Carta data for software companies, puts typical median seed dilution near 18 percent. If your plan implies giving away far more than that for one round, the milestone list is probably too ambitious for the amount, or the amount too small for the milestones.

Compare your funding sources

Carta groups the options into bootstrapping, debt and equity: with bootstrapping you keep all ownership, with debt you keep ownership but owe money, and with equity you give investors a share.

SourceWhat it costs youGood fit when
Angel investorsEquity. Individuals typically invest $25,000 to $100,000, and angel groups may average $750,000 or moreYou are pre-revenue and want early believers with industry knowledge
Venture capitalEquity, commonly estimated at 15% to 30% per roundYou need to scale fast and can support a large outcome
Federal grants (SBIR/STTR)No equity; time, compliance and waiting between phasesYou have technical risk to retire
SBA-backed loansEffective cost of roughly 8% to 11% APR, no dilutionYou have revenue or assets and predictable cash flow
Revenue-based financingA share of revenue, with estimates of 18% to 35% total costYou already have steady sales

Cost estimates differ by source and by deal, so treat these as ranges to test against real term sheets and loan offers.

Control matters as much as price. UR Ventures observes that over several equity rounds, investors commonly end up holding a majority of the shares. Founders may see that as lost control, but outside capital is often what makes growth possible. Plan your cap table through the Series A before you sign the first check.

Funding strategy for research-based startups

If your company comes out of a university lab, you have access to a source most startups do not: federal research grants. The SBIR and STTR programs provide over $2 billion annually through agency solicitations. Award sizes vary by agency and year, and published guidance puts Phase I at up to $150,000 in one source and $150,000 to $225,000 in another, with Phase II reaching up to $1 million to $1.5 million. Confirm current limits and the program's authorization status on the agency's official solicitation page before you plan around a number.

Three practical points shape how grants fit into a plan:

  • University partners can share the work. Awards go to the small business, but a portion can be subcontracted to a university lab: up to 33% for SBIR and 60% for STTR in Phase I.
  • Timing needs a bridge. The same guide flags the possible delay between Phase I and Phase II as a major drawback, so plan cash for the gap.
  • Ownership rules matter. SBIR/STTR eligibility requires the company to be at least 51% owned by U.S. citizens or permanent residents rather than by a venture fund. Check your cap table before applying, especially after a Series A.

Grants and equity work best in sequence. A grant-funded prototype or pilot dataset is the kind of evidence that makes a seed round smaller, cheaper and easier to close. Licensing terms with your university also shape what investors will fund, so settle the IP position early. For a life sciences company, our guides on life science commercialization and medical device regulatory strategy show which milestones tend to carry the most weight, and biotech market research helps you size the opportunity you will show investors.

When to raise and what to have ready

Y Combinator's guidance is to raise once you understand the market and customer and have a product being adopted quickly, and it calls 10% weekly growth for several weeks impressive. Pre-revenue deep tech founders will not have that curve, so their equivalent is technical evidence and a credible path to the next milestone.

The SEC's small business guide lists what to have before you ask, as published in February 2025:

  • An updated capitalization table naming all equity holders
  • Financial statements: balance sheet, income statement, cash flow statement and statement of shareholders' equity
  • A runway calculation based on projected expenses
  • A plan for how the proceeds will be used
  • Advisors lined up, including an attorney and an accountant

The same guidance advises targeting investors who know your industry and can add value beyond money. Building those relationships early pays off: NYU Entrepreneurship advises that founders share periodic updates on milestones and traction so investors watch them execute before the formal raise begins. JPMorgan adds that warm introductions consistently outperform cold outreach.

How a round runs from first meeting to closing

Plan for time. In the NYU account, an angel may commit after 2 to 3 conversations over a few weeks, while institutional funds typically need 4 to 6 or more meetings across multiple partners over several months.

A typical institutional process, as one law firm describes it, runs like this:

  1. A first meeting of 30 to 45 minutes with a partner or associate
  2. A partner meeting
  3. Parallel diligence, including customer calls and financial model review
  4. A term sheet, usually with a binding no-shop
  5. Legal drafting of the definitive documents
  6. Closing, when documents are signed and money arrives

The same source says diligence and documents often take 3 to 6 weeks for a priced seed round. On the legal side, Legal 500 explains that the term sheet is non-binding on valuation and governance, and lawyers then draft the stock purchase agreement, amended charter, investor rights agreement and related documents. Budget for counsel: one guide estimates company-side legal fees of $15,000 to $50,000 for a priced seed round, so confirm quotes with your own attorney.

Can you skip outside investment?

Yes. Bootstrapping keeps ownership and control with you, though growth may be slower and your own money is at risk. It suits some businesses better than others. JPMorgan notes that it works well for service businesses and niche software, and is generally not viable for capital-intensive fields such as biotech.

The growth penalty may be smaller than expected. A study of 900 early-stage SaaS companies found bootstrapped companies with $1M to $15M in ARR grew 44% year over year, against 42.8% for venture-backed peers. Harvard's startup guide adds a practical rule: design the business model around cash flow, and do not count invoiced revenue until the money arrives.

Our perspective on funding research-based companies

We work with universities, researchers and founders who have strong science and an unclear path to money. The most common mistake we see is treating funding as a separate project from IP and commercialization. Investors and grant reviewers read the same signals: who owns the technology, what the license says, what the market looks like and what the next milestone is.

Our team has worked inside major university technology transfer offices, in startup leadership, in federal grant review and in industry commercialization. That mix shapes our advice: sequence the money. Use non-dilutive funding such as SBIR/STTR to retire technical risk, settle the licensing terms early, then approach private investors with evidence rather than a story.

We also think the plan should be written down as milestones with dates and evidence. When the strategy, the IP position and the investor introductions are built together, the raise is shorter and the terms are better. Legal work is coordinated with our IP law partner so the documents match the plan.

the author

Get help building your funding plan

We help founders, researchers and universities connect IP and licensing, spinout formation, funding strategy including SBIR/STTR and non-dilutive grants, go-to-market planning and investor introductions. If you want a second set of eyes on your milestones, your grant targets or your investor list, see our consulting services.

Techtransferadvisors

Tell us your stage and your next milestone, and we will tell you which funding path fits it. You can also start from the Tech Transfer Advisors home page.

FAQ

How much should a startup raise in its first round?

Raise enough to reach the milestones the next investor will require, plus a buffer. A common planning range is 18 to 24 months of runway, and TechCrunch suggests adding 30% to 50% to your budget for slippage. Average sizes, such as roughly $3 million for a 2025 U.S. seed round, are context rather than targets.

Is grant funding better than venture capital?

They solve different problems. Grants such as SBIR/STTR do not take equity, but they bring paperwork, eligibility rules and possible gaps between phases. Venture capital brings larger sums and investor support but dilutes ownership. Many research-based companies use grants first to reduce technical risk, then raise equity.

When should I start talking to investors?

NYU Entrepreneurship advises building relationships 6 to 12 months before you plan to raise. Share short updates on progress so investors see you execute. Begin the formal raise with at least six months of cash left, and ideally more.

What documents do I need before fundraising?

The SEC lists an updated cap table, financial statements, a runway calculation, a plan for using the proceeds and advisors such as an attorney and an accountant. Add a clear milestone plan and your IP and licensing documents if the company comes from a university.

Can I fund a startup without outside investors?

Yes, through savings, early sales or loans, and you keep full ownership. It works best for businesses with low upfront costs. Capital-intensive fields such as biotech and medical devices usually need grants, investors or both.

Sources

Made with BabyLoveGrowth to earn links